Cargando…
Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients
OBJECTIVE: We sought to determine the impact of Type 2 Diabetes Mellitus (T2D) anti-hyperglycemic medications (A-HgM) on risk of Alzheimer’s disease (AD) and related dementias (ADRD) outcomes including vascular dementia, and non-AD dementia such as frontotemporal, Lewy body, and mixed etiology demen...
Autores principales: | Torrandell-Haro, Georgina, Branigan, Gregory L., Brinton, Roberta Diaz, Rodgers, Kathleen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120543/ https://www.ncbi.nlm.nih.gov/pubmed/35601622 http://dx.doi.org/10.3389/fnagi.2022.878304 |
Ejemplares similares
-
Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
por: Branigan, Gregory L., et al.
Publicado: (2022) -
Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020) -
Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
por: Branigan, Gregory L., et al.
Publicado: (2022) -
Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain
por: Branigan, Gregory L., et al.
Publicado: (2023) -
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes
por: Tang, Xin, et al.
Publicado: (2022)